Literature DB >> 10713700

Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.

D W Seol1, Q Chen, R Zarnegar.   

Abstract

Hepatocyte Growth Factor (HGF) exerts its biological effects via binding and activating a transmembrane protein tyrosine kinase receptor known as c-Met. Previous studies from our laboratory demonstrated that c-met gene expression is inducible by its own ligand (HGF). However, the molecular mechanism(s) involved in this process are unknown. The present study was carried out to address this question. Transfection of various c-met-CAT promoter constructs into the mouse hepatocellular carcinoma cell line Hepa 1-6 in combination with electrophoretic mobility shift assays (EMSA) identified the responsive element as an activated protein-1 (AP-1) binding site (TGAGTCA) within the c-met core promoter region at position -158 to -152. The c-met AP-1 element binds specifically to AP-1 protein as verified by supershift assays. EMSA studies and mutational analyses of the promoter region also revealed that the members of the Sp family of transcription factors (Sp-1 and Sp-3) bind to the c-met Sp-1 element (located at position -124) which is adjacent to the AP-1 site. We show that Sp binding dampens binding of AP-1 to its cognate site in the c-met promoter region. Stimulation of Hepa 1-6 cells with HGF resulted in a rapid and dramatic enhancement of the AP-1 binding activity as well as an overall increase in the level of AP-1 protein. Cotransfection of AP-1 expression vectors (c-Fos plus c-Jun) with c-met promoter constructs resulted in stimulation of c-met promoter activity. We found that transactivation of the c-met promoter by AP-1 can be blocked by Curcumin, an inhibitor of AP-1. Moreover, we found that the induction of the endogenous c-met gene by HGF is inhibited by the addition of Curcumin. The results demonstrate that the HGF-induced transcription of the c-met gene by HGF is, at least in part, due to activation of the AP-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713700     DOI: 10.1038/sj.onc.1203404

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.

Authors:  Markus Müller; Alessandro Morotti; Carola Ponzetto
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes.

Authors:  Jihong Ma; Chunbin Zou; Lida Guo; Danushka S Seneviratne; Xinping Tan; Yong-Kook Kwon; Jiyan An; Robert Bowser; Marie C DeFrances; Reza Zarnegar
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

3.  Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.

Authors:  Prachi Borude; Genea Edwards; Chad Walesky; Feng Li; Xiaochao Ma; Bo Kong; Grace L Guo; Udayan Apte
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

4.  Four individually druggable MET hotspots mediate HGF-driven tumor progression.

Authors:  Cristina Basilico; Anna Hultberg; Christophe Blanchetot; Natalie de Jonge; Els Festjens; Valérie Hanssens; Sjudry-Ilona Osepa; Gitte De Boeck; Alessia Mira; Manuela Cazzanti; Virginia Morello; Torsten Dreier; Michael Saunders; Hans de Haard; Paolo Michieli
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

5.  Therapeutic potential of curcumin in gastrointestinal diseases.

Authors:  Sigrid A Rajasekaran
Journal:  World J Gastrointest Pathophysiol       Date:  2011-02-15

6.  Cross-talk between steroid-receptor-mediated and cell-membrane-receptor-mediated signalling pathways results in the in vivo modulation of c-Met and ornithine decarboxylase gene expression in mouse kidney.

Authors:  M Dudkowska; A Stachurska; W Chmurzyska; B Grzelakowska-Sztabert; M Manteuffel-Cymborowska
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

7.  Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells.

Authors:  Hui-Jun Hu; Xiao-Long Lin; Mi-Hua Liu; Xiao-Juan Fan; Wei-Wen Zou
Journal:  Oncol Lett       Date:  2015-12-28       Impact factor: 2.967

8.  Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.

Authors:  Jihong Ma; Marie C DeFrances; Chunbin Zou; Carla Johnson; Robert Ferrell; Reza Zarnegar
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

9.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival.

Authors:  James Y Dai; Marie C DeFrances; Chunbin Zou; Carla J Johnson; Reza Zarnegar
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.